Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4590517014 | Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590518016 | Second dose of COVID-19 recombinant spike protein antigen immunization | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590521019 | Second dose of 2019 novel coronavirus recombinant spike protein antigen immunisation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4590523016 | Second dose of SARS-CoV-2 recombinant spike protein antigen immunization | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590524010 | Second dose of 2019-nCoV recombinant spike protein antigen vaccination | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590525011 | Second dose of 2019 novel coronavirus recombinant spike protein antigen vaccination | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4590526012 | Second dose of COVID-19 recombinant spike protein antigen vaccination | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590527015 | Second dose of 2019 novel coronavirus recombinant spike protein antigen immunization | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4590528013 | Second dose of 2019-nCoV recombinant spike protein antigen immunization | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590529017 | Second dose of COVID-19 recombinant spike protein antigen immunisation | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590530010 | Second dose of 2019-nCoV recombinant spike protein antigen immunisation | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4590531014 | Second dose of SARS-CoV-2 recombinant spike protein antigen vaccination | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 4669660012 | Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccination | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4669661011 | Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (procedure) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4669662016 | Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | Is a | Administration of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | true | Inferred relationship | Existential restriction modifier | ||
| Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 1 | |
| Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | Direct substance | Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product) | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine contraindicated | Associated procedure | True | Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | Inferred relationship | Existential restriction modifier | 1 |
| Second dose of severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen vaccine declined | Associated procedure | True | Administration of second dose of vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen | Inferred relationship | Existential restriction modifier | 1 |
This concept is not in any reference sets
FHIR